CMCC Welcomes Delta 9 as Newest Member

TORONTO, ONTARIO--(Marketwired - Nov. 10, 2015) - Today the Canadian Medical Cannabis Council (CMCC) announced that Delta 9, a Health Canada licensed producer of medical cannabis, has signed CMCC's Code of Ethics and joined CMCC as the association's newest member.

"Delta 9 is very excited to join CMCC in creating and implementing the highest standards of safety, quality, and patient access within Canada's medical cannabis industry," said John Arbuthnot, Vice President and RPIC, Delta 9.

CMCC is a medical cannabis industry association representing licensed producers and other stakeholders who are committed to building long-term trust with patients by ensuring the highest standards of ethical behaviour across the entire medical cannabis supply chain, including the interactions between licensed producers and physicians.

"We are pleased to welcome the Delta 9 team to CMCC," said CMCC interim executive director Philippe Lucas. "Every new member further galvanizes our ability to bring about positive, ethical change in the medical cannabis industry. We look forward to continuing to advocate for federal policies and industry business practices that are in the best interest of Canadian patients."

About Delta 9

Delta 9 Bio-Tech is a commercial producer of high quality medical cannabis products licensed under Health Canada's Marihuana for Medical Purposes Regulations (MMPR). Delta 9 currently operates an 80,000 square foot production and distribution facility in the Winnipeg area, serving approximately 1,000 registered clients across Canada.

About the Canadian Medical Cannabis Council (CMCC)

The Canadian Medical Cannabis Council (CMCC) is an industry group representing stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada's medical cannabis industry. All CMCC members are required to adhere to a Code of Ethics designed to serve patients' best interests.